Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 3Phase 4 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Prostatic Neoplasms 2Neoplasm, Residual 2Lymphoma 2Esophageal Stenosis 2Prostate Cancer Metastatic 1Polycystic Ovary Syndrome 1Myasthenia Gravis 1Metastatic Castration-Resistant Prostate Cancer 1Mediastinal Neoplasms 1Lymphoma, Large-Cell, Anaplastic 1Infertility 1Hodgkin Disease 1Hemangioma 1Esophageal Neoplasms 1Burkitt Lymphoma 1Barrett Esophagus 1Adrenal Insufficiency 1

Interventions

Cyclophosphamide 3Vincristine 2Methotrexate 2Ifosfamide 2Etoposide 2Doxorubicin 2Dexamethasone 2Cytarabine 2Vindesine 1Thiotepa 1Tenofovir 1Rituximab 1Radiotherapy 1Radiation 1Prednisolone 1Melphalan 1Lomustine 1Idarubicin 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Carmustine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Burkitt Lymphoma × Prednisolone × Clear all
NCT00199082 2022-08-19

Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults

Goethe University

Phase 4 Completed
650 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Mediastinal Neoplasms, Lymphoma, Large-Cell, Anaplastic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡